MX2022013814A - Tratamiento de infecciones virales. - Google Patents
Tratamiento de infecciones virales.Info
- Publication number
- MX2022013814A MX2022013814A MX2022013814A MX2022013814A MX2022013814A MX 2022013814 A MX2022013814 A MX 2022013814A MX 2022013814 A MX2022013814 A MX 2022013814A MX 2022013814 A MX2022013814 A MX 2022013814A MX 2022013814 A MX2022013814 A MX 2022013814A
- Authority
- MX
- Mexico
- Prior art keywords
- treatment
- viral infections
- infections
- invention features
- present
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title abstract 2
- 230000009385 viral infection Effects 0.000 title abstract 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención presenta el tratamiento de infecciones virales, por ejemplo, infecciones causadas por virus envueltos, mediante la administración de composiciones ricas en azufre.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063019757P | 2020-05-04 | 2020-05-04 | |
PCT/US2021/030591 WO2021226037A1 (en) | 2020-05-04 | 2021-05-04 | Treatment of viral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022013814A true MX2022013814A (es) | 2022-11-30 |
Family
ID=78468308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022013814A MX2022013814A (es) | 2020-05-04 | 2021-05-04 | Tratamiento de infecciones virales. |
Country Status (9)
Country | Link |
---|---|
US (1) | US20230165893A1 (es) |
EP (1) | EP4146227A4 (es) |
JP (1) | JP2023524269A (es) |
CN (1) | CN115484960A (es) |
AU (1) | AU2021268622A1 (es) |
BR (1) | BR112022022263A2 (es) |
CA (1) | CA3177580A1 (es) |
MX (1) | MX2022013814A (es) |
WO (1) | WO2021226037A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023159060A1 (en) * | 2022-02-16 | 2023-08-24 | Prothione Llc | Compositions and methods for the treatment of coronavirus diseases |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030235571A1 (en) * | 2002-06-19 | 2003-12-25 | Gabriel Gojon-Romanillos | Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance |
WO2010096686A1 (en) * | 2009-02-19 | 2010-08-26 | Bach Pharma, Inc. | Methods of treating intestinal diseases and inflammatory conditions related to hiv-aids |
AU2009344046B2 (en) * | 2009-04-10 | 2014-10-30 | Sleimen El Kettany | Plant composition for the treatment or prevention of viral blood-borne diseases such as diseases caused by the human immunodeficiency virus (HIV) or hepatitis C |
NZ612504A (en) * | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents |
CA2847589C (en) * | 2011-09-14 | 2019-11-26 | Nuevas Alternativas Naturales, S.A.P.I. de C.V. | Preparation and compositions of highly bioavailable zerovalent sulfur and uses thereof |
EP4331590A3 (en) * | 2013-10-29 | 2024-04-17 | President and Fellows of Harvard College | Nuclear factor erythroid 2-like 2 (nrf2) for use in treatment of age-related macular degeneration |
US9694030B2 (en) * | 2014-10-17 | 2017-07-04 | Frederick J. Sawaya | Composition for treatment, inhibition and attenuation of virus |
US20170258827A1 (en) * | 2017-05-31 | 2017-09-14 | Frederick J. Sawaya | Method for treating cancer |
-
2021
- 2021-05-04 CA CA3177580A patent/CA3177580A1/en active Pending
- 2021-05-04 US US17/922,477 patent/US20230165893A1/en active Pending
- 2021-05-04 EP EP21800731.8A patent/EP4146227A4/en active Pending
- 2021-05-04 BR BR112022022263A patent/BR112022022263A2/pt not_active Application Discontinuation
- 2021-05-04 CN CN202180032680.3A patent/CN115484960A/zh active Pending
- 2021-05-04 AU AU2021268622A patent/AU2021268622A1/en active Pending
- 2021-05-04 JP JP2022566681A patent/JP2023524269A/ja active Pending
- 2021-05-04 MX MX2022013814A patent/MX2022013814A/es unknown
- 2021-05-04 WO PCT/US2021/030591 patent/WO2021226037A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021226037A1 (en) | 2021-11-11 |
CN115484960A (zh) | 2022-12-16 |
EP4146227A1 (en) | 2023-03-15 |
EP4146227A4 (en) | 2024-01-24 |
CA3177580A1 (en) | 2021-11-11 |
AU2021268622A1 (en) | 2022-11-24 |
JP2023524269A (ja) | 2023-06-09 |
BR112022022263A2 (pt) | 2022-12-20 |
WO2021226037A8 (en) | 2021-12-30 |
US20230165893A1 (en) | 2023-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2022000453A (es) | Compuestos útiles para tratar infecciones por virus de influenza. | |
PH12021551065A1 (en) | Fused ring compounds | |
PH12018501962A1 (en) | Stablizied soluble pre-fusion rsv f proteins | |
GEP20227374B (en) | Novel, highly active pyrazolo-piperidine substituted indole-2-carboxamides active against the hepatitis b virus (hbv) | |
WO2020160193A3 (en) | Compounds and uses thereof | |
EA201890735A1 (ru) | Модуляторы корового белка вируса гепатита b | |
PH12016501254A1 (en) | Novel dihydroquinolizinones for the treatment and prophylaxis of hepatitis b virus infection | |
MX2021006902A (es) | Nuevos compuestos sulfonimidoilpurinona 7-sustituidos y derivados para el tratamiento y la profilaxis de la infeccion virica. | |
MX2019002438A (es) | Compuestos triciclicos fusionados de piridazinona utiles para tratar infecciones de orthomyxovirus. | |
MY188114A (en) | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection | |
PH12020550525A1 (en) | Novel, highly active amino-thiazole substituted indole-2carboxamides active against the hepatitis b virus (hbv) | |
PH12018502332A1 (en) | Stabilized pre-fusion rsv f proteins | |
EA202191355A1 (ru) | Стабилизированные f-белки rsv до слияния | |
CR20230100A (es) | Compuestos fosfolípidos y usos de los mismos | |
MX2018002707A (es) | Derivados de tetrahidrofurano antivirales. | |
CR20210460A (es) | Compuestos útiles en la terapia del vih | |
MX2019004029A (es) | Compuestos y metodos para diagnosis y tratamiento de infecciones virales. | |
PH12020552172A1 (en) | Cyclic dinucleotides as sting agonists | |
MX2022016066A (es) | Nuevo inhibidor de proteina-cinasa-cinasa activada por mitogeno (mek) para el tratamiento de infecciones virales y bacterianas. | |
MX2022013814A (es) | Tratamiento de infecciones virales. | |
WO2022169961A8 (en) | Sigma receptor ligands for treating sars-cov-2 infection | |
MX2022000232A (es) | Composiciones y metodos para tratar o evitar infecciones oculares con filociclovir. | |
WO2019070709A8 (en) | Compounds for treating or preventing flavivirus infections | |
EA202092149A1 (ru) | Композиции, содержащие бактериальные штаммы | |
EA202190513A1 (ru) | Композиции и способы для лечения пигментного ретинита |